Escolha um dos esquemas ou associe-os.
Esquema B: Antibioticoterapia se sepse neonatal associada.
Associação:
I.
Ampicilina
por no mínimo 10 dias EV, doses conforme idade gestacional (IG) e dias de vida.
+
II.
Gentamicina
EV, doses conforme idade gestacional (IG) e dias de vida.
1. Um regime de sedação com opióide geralmente é suficiente.
Avaliar condicões clínicas e hemodinâmicas do paciente e dar o suporte necessário.
Autoria principal:
Dolores Silva (Pediatria pela UERJ).
Revisão:
Maria Eduarda B. Cruxen (Pediatria pela UFCSPA).
Kliegman RM, Geme JS, Schor NF, et al. Nelson textbook of pediatrics.19th ed. Philadelphia: Elsevier; 2011.
Cloherty JP. Manual de neonatologia. 7 ed. Rio de Janeiro: Guanabara Koogan; 2015.
Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997; 336(9):597-604.
Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics. 1998; 101(3 Pt 1):325-34.
Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med. 2000; 342(7):469-74.
Hansmann G, Apitz C, Abdul-Khaliq H, et al. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016; 102(Suppl 2):86.
Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019; 38(9):879-901.
Berger RM, Haworth SG, Bonnet D, et al. FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion. Int J Cardiol. 2016; 202:52-8.
Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J. 2019; 53(1):1801916.
Abman SH, Hansmann G, Archer SL, et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015; 132(21):2037-99.
Beghetti M, Gorenflo M, Ivy DD, et al. Treatment of pediatric pulmonary arterial hypertension: A focus on the NO-sGC-cGMP pathway. Pediatr Pulmonol. 2019; 54(10):1516-26.
Sociedade Brasileira de Pediatria. Tratado de Pediatria. 5 ed. São Paulo: Manole; 2021.
Kliegman RM, St. Geme JW. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2020.